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Abstract
Although trauma-focused cognitive behavior therapy (TF-CBT) is the frontline treatment for post-traumatic stress
disorder (PTSD), up to one-half of patients are treatment nonresponders. To understand treatment nonresponse, it is
important to understand the neural mechanisms of TF-CBT. Here, we used whole-brain intrinsic functional connectivity
analysis to identify neural connectomic signatures of treatment outcome. In total, 36 PTSD patients and 36 healthy
individuals underwent functional MRI at pre-treatment baseline. Patients then underwent nine sessions of TF-CBT and
completed clinical and follow-up MRIs. We used an established large-scale brain network atlas to parcellate the brain
into 343 brain regions. Pairwise intrinsic task-free functional connectivity was calculated and used to identify pre-
treatment connectomic features that were correlated with reduction of PTSD severity from pretreatment to post
treatment. We formed a composite metric of intrinsic connections associated with therapeutic outcome, and then
interrogated this composite metric to determine if it distinguished PTSD treatment responders and nonresponders
from healthy control status and changed post treatment. Lower pre-treatment connectivity for the cingulo-opercular,
salience, default mode, dorsal attention, and frontoparietal executive control brain networks was associated with
treatment improvement. Treatment responders had lower while nonresponders had significantly greater connectivity
than controls at pretreatment. With therapy, connectivity significantly increased for responders and decreased for
nonresponders, while controls remain unchanged over this time period. We provide evidence that the intrinsic
functional architecture of the brain, specifically connectivity within and between brain networks associated with
external vigilance, self-awareness, and cognitive control, may characterize a positive response to TF-CBT for PTSD.
Introduction
Trauma-focused cognitive behavior therapy (TF-CBT)
is the preferred treatment for post-traumatic stress dis-
order (PTSD), yet at least half of patients do not respond
to this approach1,2. To understand why only some people
respond to treatment, it is crucial to elucidate the neu-
robiological mechanisms of TF-CBT. Functional magnetic
resonance imaging (fMRI) studies have shed light on
some of the neurobiological predictors of this treatment,
with the predictive patterns of activations in specific
regions, depending on the task employed3–5. A review of
these studies concluded that TF-CBT response was pre-
dicted by elevated dorsal anterior cingulate prior to
treatment, whereas elevated amygdala and insula activa-
tion was associated with treatment failure6. In terms of
the effects of TF-CBT, other studies have found that TF-
CBT resulted in decreased activation of the amygdala and
insula, and increased activation in the dorsal anterior
cingulate cortex and hippocampus6. Limited studies have
also examined how task- dependent connectivity
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associated with some of these brain regions correlates
with treatment, with greater suppression of
amygdala–insula connectivity during cognitive reappraisal
of negative-valence images7, and that of insula–pregenual
anterior cingulate connectivity during processing of sad
facial expressions associated with symptom
improvement8.
While such a focused approach has been useful to
identify neural regions underlying TF-CBT response, it is
limited because it does not address how treatment
response may be predicted by task-independent core-
intrinsic connectivity within and between brain networks.
The few studies investigating changes in resting-state
connectivity following TF-CBT have reported increases
between the amygdala and hippocampal limbic network
structures with the executive top-down control prefrontal
brain regions9, and a reduction in salience network con-
nectivity10. Two recent studies have also evaluated the
extent to which pre-treatment resting connectivity is
associated with TF-CBT response. The first study used a
combination of resting-state connectivity within the
ventral attention network and delayed recall performance
in a verbal memory task to predict the response to TF-
CBT11. The second study identified that pre-treatment
superior frontal and presupplementary motor-resting
connectivity could distinguish veterans with PTSD who
respond to TF-CBT from nonresponders12. However,
these studies are also limited in that they focus either on
specific regions or networks, and lack detailed examina-
tion of all connections in the brain.
Mapping the functional architecture of the entire brain,
commonly referred to as the functional connectome,
allows a holistic and integrated system-level under-
standing of how intrinsic functional networks of the brain
are associated with treatment response. This approach
can offer novel insights into how existing treatments
work, to develop new treatments and potentially lead to
new biomarkers for monitoring the effects of treatment.
PTSD has been characterized by disruptions within these
intrinsic brain networks13–15. For example, enhanced
connectivity of brain regions associated with salience
processing and hypervigilance (i.e., the salience network)
but at the expense of awareness of internally focused
thoughts, autobiographical memory, and compromised
cognitive abilities (i.e., weakly connected and hypoactive
default mode (DMN) and frontoparietal (FPN) or central
executive brain networks, respectively) underlies PTSD16.
Despite the number of studies investigating the rela-
tionship between task-driven activation and connectivity
of specific neural regions and treatment response to
PTSD6,17, no prior studies have reported a systematic
connectome-wide inspection of the detailed intrinsic
functional architecture of the entire brain in the context
of TF-CBT. Here, we adopted a comprehensive,
connectome-wide approach18 to investigate large-scale
intrinsic functional brain networks prior to treatment that
characterize response to TF-CBT. We analyzed intrinsic
functional connectivity from fMRI scans collected prior to
and following a 9-week course of TF-CBT. We also
examined whether connectivity within the response-
related brain networks at baseline differs between PTSD
and healthy participants, and whether it changes with
treatment. We hypothesized that pre-treatment func-
tional connectivity related to the salience, limbic, and
frontoparietal brain networks is likely to characterize
response to TF-CBT, to differ between PTSD and healthy
individuals, and that connectivity will change following
treatment.
Materials and methods
Participants and study protocol
Participant recruitment for the study commenced from
August 2009. Participants were 51 treatment-seeking
patients, 36 of whom had viable imaging data at base-
line and 25 of these with follow-up MRI data (mean age
39.7 ± 11.3 years, 17 females; see CONSORT diagram in
Supplementary Fig. 1 and participant characteristics in
Table 1); PTSD, as defined by DSM-IV, was diagnosed by
Masters-level clinical psychologists using the Clinician
Administered PTSD Scale (CAPS19). Participants with a
history of neurological disorder, moderate or severe
traumatic brain injury, psychosis, bipolar disorder, or
substance dependence were excluded. The protocol per-
mitted prescribed medication if the dosage had remained
stable for 2 months prior to the scan, and was not altered
during the course of the study; 10 (27.8%) participants
were taking selective serotonin-reuptake inhibitors.
The study also included a comparison group of 36
healthy participants (mean age 38.3 ± 12.9 years, 18
females) screened using the Mini International Neu-
ropsychiatric Interview (MINI version 5.520). All controls
underwent baseline MRI scans, and 22/36 controls com-
pleted follow-up scans. Depression and anxiety levels
were also assessed by self-report on the depression,
anxiety, and stress scale (DASS21).
The authors assert that all procedures contributing to
this work comply with the ethical standards of the rele-
vant national and institutional committees on human
experimentation, and with the Helsinki Declaration of
1975, as revised in 2008. The study was approved by the
Western Sydney Area Health Service Human Research
Ethics Committee (Approval#ETH00309), and written
informed consent was obtained from participants.
Treatment protocol
Within 2–3 weeks of scanning, participants commenced
a course of nine once-weekly individual sessions of TF-
CBT that were delivered by experienced doctoral-level or
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masters-level clinical psychologists. This therapy involved
an initial session of psychoeducation about psychological
responses to trauma, then six sessions of 40-min imaginal
exposure to the trauma memory, instructions regarding
in vivo exposure to avoided situations, and cognitive
restructuring of thoughts related to the traumatic event22.
An additional session reinforced cognitive restructuring
exercises, and a final session focused on relapse preven-
tion. This therapy procedure is consistent with gold-
standard TF-CBT protocols23. Independent clinicians
rated the fidelity of 130 sessions (18%), indicating full
adherence to the treatment protocols and high level of
quality on a 7-point scale (mean ± SD= 6.11 ± 1.32). A
post-treatment assessment using the CAPS was con-
ducted by an independent clinical psychologist 1 week
following completion of the course of treatment. To
examine change in PTSD severity independent of initial
severity, residual change was calculated from a regression
of pre-treatment total CAPS scores on post-treatment
total CAPS scores24 (higher change scores correspond to
greater improvement), and was correlated with neural
measures.
fMRI acquisition, preprocessing, and generation of
functional connectomes
Details of MRI acquisition, activation tasks, preproces-
sing, and intrinsic functional connectivity estimation were
published previously25–27 and can be found in Supple-
mentary Materials. In brief, MRI data for both visits
were acquired on a 3 T GE Signa HDx scanner using an
8-channel head coil. MRI acquisition included five fMRI
tasks (a Go/NoGo cognitive task, conscious and non-
conscious emotion face processing, and two runs of
cognitive reappraisal task) (echo-planar imaging; TR/
TE= 2500/27.5 ms, flip angle= 90°, 64 × 64 matrix, 40
axial 3.5-mm slices, and 120 volumes) and a 3D T1-
weighted structural MRI scan (TR/TE= 8.3/3.2 ms, flip
angle= 11°, TI= 500 ms, 256 × 256 matrix, and
Table 1 Participant characteristics for PTSD (treatment responders and nonresponders) and healthy controls.
PTSD (n= 36) Controls
(n= 36)
Treatment responders
(n= 25)
Treatment nonresponders
(n= 11)
Age, mean (SD) 39.7 ± 11.3 38.3 ± 12.9 40.2 ± 12.4 38.6 ± 8.6
Male, n (%) 53% 50% 48% 63.6%
Time since trauma, months mean (SD) 17.5 ± 14.0 — 18.6 ± 15.3 14.9 ± 10.6
Type of trauma, n (%) —
Childhood abuse 3 (8.3) — 3 (12) 0 (0)
Motor vehicle accident 5 (13.9) — 2 (8) 3 (27.3)
Police-related trauma 10 (27.8) — 8 (32) 3 (27.3)
Assault 14 (38.9) — 9 (36) 5 (36.4)
Witness 3 (8.3) — 3 (12) 0 (0)
Prescribed SSRI, n (%) 10 (27.8) — 8 (32) 2 (18.2)
Major depressive disorder, n (%) 19 (52.8) — 12 (48) 7 (63.6)
Social phobia, n (%) 15 (41.7) — 8 (32) 7 (63.6)
Panic disorder, n (%) 5 (13.9) — 4 (16) 1 (9.1)
Agoraphobia, n (%) 23 (63.9) — 17 (68) 6 (54.6)
Obsessive compulsive disorder, n (%) 4 (11.1) — 2 (8) 2 (18.2)
Generalized anxiety disorder, n (%) 12 (33.3) — 8 (32) 4 (36.4)
DASS depression, mean (SD) 10.9 ± 5.5 — 10.5 ± 5.8 11.8 ± 3.9
DASS anxiety, mean (SD) 8.1 ± 4.4 — 7.2 ± 4.8 10.1 ± 2.3
DASS stress, mean (SD) 12.0 ± 4.4 — 11.4 ± 4.6 13.5 ± 3.5
Baseline CAPS severity, mean (SD) 72.2 ± 14.0 — 71.9 ± 20.1 72.7 ± 11.1
Post-treatment CAPS severity, mean (SD) 27.5 ± 19.6 — 17.2 ± 12.1* 51.0 ± 10.8*
PTSD post-traumatic stress disorder, CAPS clinician-administered PTSD scale, DASS21 depression anxiety stress scale—21 items.
* indicates a significant difference at P < 0.05 between treatment responders and nonresponders.
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180 sagittal 1-mm slices). Intrinsic functional con-
nectivity was estimated using data from all five tasks.
fMRI images were motion-corrected and corrected for
geometric distortions using realignment and unwarping,
slice time corrected, spatially normalized to the stereo-
tactic MNI space, and smoothed. As motion is a critical
issue in resting-state data, data volumes associated with
high movement (framewise displacement from one time
point to the next) or changes in BOLD signal intensity
were censored (temporally masked) to reduce the
influence of motion and related artifacts28,29. For each
fMRI task, the BOLD responses for each experimental
condition were modeled in the general linear model
framework along with the mean signal time course
extracted from eroded ventricle and white matter masks,
as well as the temporal masks derived from the volume
censoring described above, and motion effects using the
Volterra expansion of the realignment parameters. To
isolate an estimate of intrinsic functional connectivity,
we regressed voxelwise BOLD time series against the
model incorporating task covariates as nuisance signals
and analyzed the residuals of this model. Subsequent to
this denoising procedure, the time series were band-pass
filtered (0.009 Hz < f < 0.08 Hz). Intrinsic connectivity
estimated using this approach has been previously
validated with task-free resting-state connectivity30.
Functional connectomes were generated and analyzed
using our previously published procedure27. We parcel-
lated every individual’s brain image into 343 brain regions
or nodes using a high-resolution 333 cortical template
based on Gordon et al.31 and 10 subcortical regions
obtained from the AAL atlas. This template uses resting-
state functional connectivity patterns to define brain
parcels that represent putative, functionally coherent,
brain areas providing a label based on intrinsic functional
brain networks. Intrinsic functional time series were
extracted for each of the regions and correlated with every
other region to obtain a 343 × 343 interregional functional
connectivity matrix for every individual. We transformed
the correlation coefficients into z scores using Fisher’s z
transformation. The specific choice of a parcellation
scheme can impact the results of a network analysis32–34;
hence, we tested the robustness of findings using a second
anatomical parcellation based on the AAL atlas35 (see
Supplementary Materials).
Statistical analyses
The statistical analysis was designed in a stepwise
manner to address the study aims as follows.
To identify connectome features associated with TF-CBT
treatment response
The network-based statistic (NBS)36 was used to assess
associations between pre-treatment functional connectivity
and improvement in PTSD symptoms. Analogous to
cluster-based correction strategies used in voxelwise MRI
studies, the NBS deals with the multiple-comparison pro-
blem posed by connectomic data by evaluating the null
hypothesis at the level of interconnected subnetworks
rather than individual connections. We used a primary
component- forming threshold of P < 0.001 to identify all
significant interregional connections correlated with
symptom improvement, and then tested for statistical
significance of the size of the connected components
relative to an empirical null distribution generated by
random shuffling of the order of individuals within the
group using 5000 permutations. This gives a corrected
P value for each observed component.
Observed components with P < 0.05, componentwise
corrected, were identified as significant subnetworks
associated with treatment improvement. Functional con-
nectivity estimates for each interregional connection of
the identified subnetwork were extracted. We computed a
single composite connectivity metric averaged across all
the significant connections of this subnetwork for the
subsequent analyses below. To unpack findings further at
the known intrinsic network level, we computed an
average connectivity estimate for each of the labeled
intrinsic functional network pair combinations that
characterized this network (see Supplementary Table S1).
To control for multiple testing due to the number of
measures, we employed a Benjamini–Hochberg FDR-
corrected P < 0.05 for statistical evaluation.
In supplementary analyses, we tested for associations
between connectivity with demographic and clinical
symptom measures, and retested associations with treat-
ment improvement controlling for these measures. To
understand the individual-level predictive value and pro-
vide an operational example of how the connectivity
markers we identified could be helpful in a treatment
decision, and to inform future studies, we tested the
average connectivity estimates for the network as poten-
tial predictors of treatment outcome (quantified as a
binary response variable corresponding to a 50% decrease
in symptoms) using leave-one-out cross-validation ana-
lyses. We evaluate the additive predictive value relative to
demographic and clinical measures in this analysis.
Does the treatment response-related connectomic feature
also characterize PTSD disease state at baseline?
We compared the composite connectivity metrics (i.e.,
average for the identified network feature and also average
connectivity estimates for each labeled intrinsic functional
network pair combinations that characterized this net-
work feature) using an ANOVA with group (PTSD/con-
trol) as a between-participant factor. In addition, we also
split the PTSD group into responders and nonresponders
(with responders defined as having at least 50%
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improvement in symptoms) and evaluated each group
separately relative to controls. This was done to evaluate if
responders or nonresponders have a similar/abnormal
connectivity profile relative to healthy individuals prior to
treatment. To investigate beyond the identified subnet-
work, we also performed an exploratory whole-brain
connectivity comparison between the PTSD and control
groups using NBS (Supplementary Analyses).
Does the treatment response-related connectomic feature
change after treatment?
We used an ANOVA with pre- versus post assessment
(time) as a within-participant factor and group (with levels
for PTSD depending on treatment response and controls)
as a between-participant factor to evaluate treatment
effects on changes in the composite connectivity metrics
described above. We tested for the interaction between
pre–post assessment and group, and performed post hoc
tests to characterize any significant interaction.
For all analyses above, we controlled multiple testing
using the Benjamini–Hochberg FDR- corrected P < 0.05
for statistical evaluation.
Results
Pre-treatment connectome features associated with TF-
CBT treatment response
The NBS analysis identified a connectomic signature
comprising 122 interregional connections between 88
brain nodes, which was significantly associated with
treatment response (lower baseline connectivity asso-
ciated with greater improvement in symptoms; P= 0.044
corrected for multiple comparisons, Fig. 1).
This connectomic signature was largely characterized
by (a) lower intranetwork intrinsic functional connectivity
associated with treatment improvement within the cin-
gulo-opercular, DMN, dorsal attention, and salience net-
works; also, lower internetwork connectivity associated
with treatment improvement; (b) between the regions of
the cingulo-opercular, DMN, dorsal attention, and fron-
toparietal networks; (c) between regions of the cingulo-
opercular, dorsal attention, and frontoparietal networks
with auditory and visual networks; (d) between basal
ganglia regions of the subcortical network with the DMN,
cingulo-opercular, frontoparietal, and salience networks;
(e) between the visual and somatomotor networks. Con-
nectivity was associated with anxiety levels measured on
the DASS and the presence of a comorbid condition, but
remained significantly associated with improvement in
symptoms controlling for both these measures.
This connectivity signature significantly improved pre-
dictive accuracy in classifying responders from non-
responders compared with a model using demographic
and clinical measures alone (P < 0.001; Supplementary
Table S2: cross-validated accuracy of the model without
connectivity/with connectivity= 64.3%/71.4%, sensitivity=
25.0%/100.0%, and specificity= 80.0%/60.0%). Finally, the
connectivity signature was replicated using the second
parcellation scheme (Supplementary Table S3).
Does the treatment response-related connectomic feature
also characterize PTSD at baseline?
At baseline, controls were not significantly different
compared with the whole PTSD cohort for connectivity in
this signature (P > 0.05). However, responders had a sig-
nificantly lower average connectivity than controls (P=
0.021); in contrast, nonresponders had a significantly
greater average connectivity than controls (P= 0.017).
Specifically, only connections between the frontoparietal
and cingulo-opercular brain networks were found sig-
nificant after correcting for multiple comparisons where
nonresponders had significantly greater connectivity than
controls (FDR P < 0.001, Table 2).
Does the treatment response-related connectomic feature
change after treatment?
A significant group × time interaction was observed for
average connectivity in this signature (P < 0.001), and
specifically only for connections between the somato-
motor and visual networks (FDR P < 0.05, Table 2 and Fig. 2).
Post hoc contrasts indicated that average connectivity for
this signature remained unchanged for controls over time,
but increased for treatment responders (P= 0.011) and
decreased for nonresponders (P= 0.015) following treat-
ment. Connectivity for both responders and non-
responders was not different from controls post
treatment. Only an increase in connectivity between
visual and somatomotor networks was found significant in
responders (FDR P= 0.001).
Discussion
Using a comprehensive, connectome-wide analysis, we
examined pre-treatment intrinsic functional connectivity
associated with response to 9 weeks of TF-CBT treatment
in PTSD individuals. To our knowledge, this is the first
evidence of a connectome-wide inspection of intrinsic
neural connectivity within and between key large-scale
brain networks to predict response to TF-CBT in PTSD.
We found an overall lower-than-normal pre-treatment
connectivity to be associated with better treatment
response, whereas greater-than-normal connectivity was
associated with nonresponse to TF-CBT.
Previous studies have shown that brain regions in the
limbic, cognitive, and salience brain networks were pro-
bed by functional tasks to be associated with TF-CBT37.
Connectivity in these three networks has consistently
been reported abnormal in PTSD14. Our study provides
new evidence that task-free intrinsic functional con-
nectivity in some of these brain networks is also
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associated with response to TF-CBT. This highlights that
the core functional architecture of these networks is
associated with treatment response. Specifically, we found
lower connectivity in networks underlying vigilance and
tonic alertness, such as cingulo-opercular, salience, and
dorsal attention, to be associated with better response to
TF-CBT. PTSD is characterized by hypervigilance to
threat cues, which is reflected in hyperactivity and
hyperconnectivity of brain regions associated with these
networks during processing of threat stimuli38. It is pos-
sible that lower intrinsic connectivity in these networks
prior to treatment reflects patients’ tendencies to not
engage in excessive vigilance and reactivity, which may
promote better response to behavioral strategies that
involve reduced reactivity to threat. The basal ganglia, a
group of subcortical nuclei, are also involved in voluntary
component of the behavioral expression of emotion via
their interaction with some of the threat-processing lim-
bic brain regions such as the amygdala39. This may also
explain the lower connectivity between the basal ganglia
with the DMN, cingulo-opercular, frontoparietal, and
salience networks observed to be associated with better
treatment response.
We also observed that lower connectivity of the cin-
gulo-opercular, salience, and dorsal attention networks
with the frontoparietal cognitive control brain network
was associated with better response. One of the main
tenets for TF-CBT is the capacity to reappraise events and
responses associated with the traumatic experience, such
that they are experienced with less anxiety40. The cogni-
tive control network of the brain is known to play a
crucial role in reappraising traumatic events and experi-
ences41. Moreover, impairments in this network have
been shown to predict poor response to TF-CBT42,43. Our
results seem to suggest that hypervigilance or greater
tonic alertness, reflected as greater connectivity in cin-
gulo-opercular, salience, and dorsal attention networks
associated with these processes, could possibly be dam-
pening reappraisal-related brain networks, thereby redu-
cing the individual’s ability to utilize TF-CBT. Specifically,
Fig. 1 Pre-treatment functional connectivity across the whole-brain network in PTSD patients associated with symptom improvement
following TF-CBT. The connectomic feature identified from the NBS analysis is shown below (a) from sagittal and axial views. (b) Intra- (loops) and
internetwork connections characterizing this connectomic feature are shown. The thickness of the line corresponds to the number of significant
connections relative to all possible connections between two networks, i.e., thicker lines imply more number of connections between networks. c
Hypoconnectivity in this network at baseline corresponds with greater changes in CAPS scores and subsequently greater improvement in symptoms,
such that (d) connectivity in this network at baseline is distinct between responders, nonresponders, and controls. Connectivity within the PTSD-
response groups is normalized post treatment. Bar plots (means and SD) showing average connectivity estimates at baseline and post treatment for
each group. Asterisks indicate significant post hoc findings (P < 0.05) for this interaction. BG basal ganglia, CO cingulo-opercular, DAN dorsal
attention, DMN default-mode network, FPN frontoparietal, SAL salience, SMH somatomotor hand, VAN ventral attention.
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Fig. 2 Pre- and post-treatment functional connectivity across the significant networks that were associated with PTSD symptom
improvement following TF-CBT. Network links with a significant Time*Group interaction are shown. This includes connectivity between the (a)
auditory and CO network, (b) the FPN and CO network, (c) the FPN and DMN, (d) the FPN and VAN, (e) the DAN and visual network, (f) the DMN and
regions of the basal ganglia, and (e) the SMH and visual network. *indicates post hoc comparisons significant at FDR P < 0.05. BG basal ganglia, CO
cingulo-opercular, DMN default-mode network, DAN dorsal attention, FPN frontoparietal, SMH somatomotor hand, VAN ventral attention.
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nonresponders in our analysis had abnormally higher
connectivity between cingulo-opercular and frontopar-
ietal brain networks. In contrast, PTSD individuals who
have reduced connectivity between these networks, have
better capacity to learn skills to reappraise traumatic
experiences and hence respond to treatment due to a less-
disturbing influence of this salience-related connectivity
on the cognitive brain networks.
We also observed reduced connectivity within regions
of the DMN, and between the DMN and the frontopar-
ietal network, to be associated with better response to TF-
CBT. The DMN is associated with self-referential pro-
cessing and rumination of autobiographical memories,
and is anti-correlated with networks involved in attending
to functions such as attentional vigilance, cognitive con-
trol, and orienting44. A decreased DMN connectivity due
to a shift in focus from internal thoughts to external
vigilance has been observed in PTSD45,46. It is possible
that reduced DMN-related connectivity associated with
treatment improvement reflects a reduced focus on
trauma memories, which leads to better treatment
response. It is also possible that reduced coupling of the
DMN with the frontoparietal brain regions could mean
less interference with goal-oriented tasks47 such as learn-
ing reappraisal skills, and thereby benefit from TF-CBT.
PTSD is known to impact sensory processing, particu-
larly visual processing. For example, severe emotional
trauma produces recurrent and vivid unpleasant sensory
recollections that impact visual processing even at the
preattentive level48. In our analysis, lower connectivity
related to the visual brain regions, particularly to the other
sensory somatomotor brain regions, was associated with
better treatment outcome with responders demonstrating
an increase in this connectivity to normal levels following
treatment.
To our knowledge, only two other studies have pre-
viously reported on pre-treatment resting fMRI con-
nectivity to predict clinical outcome to TF-CBT in PTSD.
Etkin et al.11 found that resting-state connectivity within
the ventral attention network alone was not able to
moderate treatment outcome. However, this connectivity
in combination with a measure of verbal memory- delayed
recall was able to predict treatment outcome with 85%
accuracy. The other study by Zhutovsky et al.12 found an
individual-level accuracy of 81.4% using resting-state
connectivity associated with the presupplementary
motor area to characterize responders. We observed a
71.4% accuracy in our analysis. Although we employed a
cross-validation approach, these estimates should be
interpreted with caution, considering the small-sample
size and within- cohort cross-validation. Importantly,
connectivity measures significantly improved the pre-
dictive capacity relative to demographic and clinical
measures alone.
Our study also provides insight into how TF-CBT
impacts neural connectivity based on heterogeneity of
treatment response. TF-CBT has shown to increase
amygdala and hippocampal connectivity to the orbito-
frontal and medial prefrontal brain cortices9. This
increase has been associated with improved capacity for
inhibition and re-evaluation of threat and heightened
memory ability9. Importantly, this increase in connectivity
was to normal levels at the end of treatment. We did not
specifically evaluate connectivity related to the amygdala
and hippocampus because pre-treatment connectivity
related to these regions was not associated with treatment
outcome in our analysis. However, we observed that the
effect of TF-CBT was to normalize intrinsic connectivity
in our identified connectome feature in different ways for
responders and nonresponders. PTSD patients who
responded to TF-CBT had lower average connectivity in
the identified connectomic feature prior to treatment, and
demonstrated an increase in this connectivity (particularly
in the somatomotor–visual and frontoparietal–DMN
connections) to normal healthy levels following treat-
ment; nonresponsive patients had greater connectivity at
baseline (particularly in the dorsal attention–visual and
cingulo-opercular–auditory/insula connections), which
was also found to normalize post treatment. This might
suggest that the overall effect of TF-CBT is to normalize
the response-related intrinsic neural connections, irre-
spective of treatment outcome. These connectivity results
complement findings from task-based activation studies
that also observe differential changes of pre-treatment
levels of recruitment in the salience (anterior cingulate
and insula) and limbic (amygdala) brain regions following
treatment49–51. These studies however lacked comparison
with controls post treatment.
We note that previous studies have reported that
resting-state connectivity is altered in PTSD14. However,
we did not observe connectivity differences between the
PTSD cohort as a whole and controls either at the whole-
brain connectome level or within the network-identified
feature associated with treatment response. Noting that
the majority of previous work has focused on specific
networks or resting-state connectivity related to specific
regions of interest14, it is likely that our available sample
size is limited to have enough power to identify whole-
brain connectome differences relative to controls. It is
also likely that the specific identified prognostic network
feature may not be able to characterize PTSD diagnosis.
The following limitations should be considered. We did
not include a wait-list comparison group, which would
have provided a stricter index of the predictive capacity of
baseline neural measures on TF-CBT relative to sponta-
neous remission. However, spontaneous remission is
unlikely in our sample for which the mean time since
trauma exposure was 3 years, and most spontaneous
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remission from PTSD occurs within the first 12 months.
Our sample size is relatively small for building predictive
models, and these models are likely prone to overfitting.
Also, although we employed a leave-one-out cross-vali-
dation, we are testing a feature in the same sample that
was used to identify that feature, this could overestimate
the generalizability. Our overall goal with this analysis was
primarily to evaluate if the connectivity measures con-
tribute significantly on top of easily obtainable demo-
graphic and clinical measures, and importantly
understand the neural mechanisms of treatment response
rather than evaluate predictive utility. Testing this pre-
dictive model in a larger and independent cohort would
give a more reliable estimate of the predictive capacity of
the identified neural features. Some of the PTSD patients
in our study also failed to complete the imaging protocol
at follow-up, which reduced the available sample size for
the follow-up imaging data, especially after splitting
responders and nonresponders. Hence, our follow-up
findings should be interpreted with caution, and need to
be tested using a large cohort. A proportion of partici-
pants were using SSRIs. However, supplementary analyses
indicated that all significant results were observed in
nonmedicated participants (Supplementary Table S4).
In summary, lower-than-normal intrinsic connectivity
within brain networks associated with external vigilance,
self-awareness, and cognitive control may be a key
mechanism for optimal response to TF-CBT. The effect of
TF-CBT is to normalize this network architecture.
Functionally probed activation and connectivity related to
these networks are known to underlie the response to TF-
CBT in PTSD. Our results suggest that this relationship
extends beyond the contextual task, and the core under-
lying functional architecture of these networks is equally
important in understanding the response to TF-CBT.
This provides new insight into understanding the neural
circuit mechanisms of TF-CBT in PTSD.
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